Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study, Lancet Lond Engl, pp.31442-31445, 2017. ,
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol (Berl), vol.131, issue.803, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01479018
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas, J Natl Cancer Inst, vol.90, pp.1473-1482, 1998. ,
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial, J Clin Oncol, vol.24, pp.2715-2737, 2006. ,
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: intergroup Radiation Therapy Oncology Group Trial 9402, Intergroup Radiation Therapy Oncology Group Trial 9402, vol.24, pp.2707-2721, 2006. ,
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951, J Clin Oncol, vol.31, 2013. ,
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402, J Clin Oncol, vol.31, 2013. ,
Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma, N Engl J Med, vol.374, pp.1344-55, 2016. ,
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas, Lancet Oncol, vol.18, pp.30194-30202, 2017. ,
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide, J Clin Oncol, vol.27, pp.5874-80, 2009. ,
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide, Neuro-Oncol, vol.18, pp.1529-1566, 2016. ,
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study, Lancet Oncol, vol.17, issue.16, pp.30313-30321, 2016. ,
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors, J Neurooncol, vol.116, pp.161-169, 2014. ,
Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial, J Clin Oncol, vol.27, pp.3712-3734, 2009. ,
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH, J Clin Oncol, vol.32, pp.783-90, 2014. ,
A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951, Clin Cancer Res, vol.17, 2011. ,
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma, Acta Neuropathol (Berl), vol.128, pp.561-71, 2014. ,
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome-and transcriptome-wide profiling improves stratification of prognostically distinct patient groups, Acta Neuropathol (Berl), vol.129, pp.679-93, 2015. ,
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities, Acta Neuropathol (Berl), vol.130, 2015. ,
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial, J Neurosurg, vol.109, pp.835-876, 2008. ,